Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer
M. Ihnen*, R. M. Wirtz, K. T. Kalogeras, K. Milde-Langosch, M. Schmidt, I. Witzel, A. G. Eleftheraki, C. Papadimitriou, F. Jänicke, E. Briassoulis, D. Pectasides, A. Rody, G. Fountzilas, V. Müller
Dive into the research topics of 'Combination of osteopontin and activated leukocyte cell adhesion molecule as potent prognostic discriminators in HER2- and ER-negative breast cancer'. Together they form a unique fingerprint.